Cargando…
Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research?
Infectious diseases are among the main causes of death and disability in developing countries, and they are a major reason for the health disparity between rich and poor countries. One of the reasons for this public health tragedy is a lack of lifesaving essential medicines, which either do not exis...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592259/ https://www.ncbi.nlm.nih.gov/pubmed/23343639 http://dx.doi.org/10.1017/S1744133112000321 |
_version_ | 1782262102027665408 |
---|---|
author | Mueller-Langer, Frank |
author_facet | Mueller-Langer, Frank |
author_sort | Mueller-Langer, Frank |
collection | PubMed |
description | Infectious diseases are among the main causes of death and disability in developing countries, and they are a major reason for the health disparity between rich and poor countries. One of the reasons for this public health tragedy is a lack of lifesaving essential medicines, which either do not exist or badly need improvements. In this article, we analyse which of the push and pull mechanisms proposed in the recent literature may serve to promote research into neglected infectious diseases. A combination of push programmes that subsidise research inputs through direct funding and pull programmes that reward research output rather than research input may be the appropriate strategy to stimulate research into neglected diseases. On the one hand, early-stage (basic) research should be supported through push mechanisms, such as research grants or publicly financed research institutions. On the other hand, pull mechanisms, such as prize funds that link reward payments to the health impacts of effective medicines, have the potential to stimulate research into neglected diseases. |
format | Online Article Text |
id | pubmed-3592259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-35922592013-03-08 Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research? Mueller-Langer, Frank Health Econ Policy Law Articles Infectious diseases are among the main causes of death and disability in developing countries, and they are a major reason for the health disparity between rich and poor countries. One of the reasons for this public health tragedy is a lack of lifesaving essential medicines, which either do not exist or badly need improvements. In this article, we analyse which of the push and pull mechanisms proposed in the recent literature may serve to promote research into neglected infectious diseases. A combination of push programmes that subsidise research inputs through direct funding and pull programmes that reward research output rather than research input may be the appropriate strategy to stimulate research into neglected diseases. On the one hand, early-stage (basic) research should be supported through push mechanisms, such as research grants or publicly financed research institutions. On the other hand, pull mechanisms, such as prize funds that link reward payments to the health impacts of effective medicines, have the potential to stimulate research into neglected diseases. Cambridge University Press 2013-01-24 2013-04 /pmc/articles/PMC3592259/ /pubmed/23343639 http://dx.doi.org/10.1017/S1744133112000321 Text en © Cambridge University Press 2013 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>. The written permission of Cambridge University Press must be obtained for commercial re-use. |
spellingShingle | Articles Mueller-Langer, Frank Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research? |
title | Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research? |
title_full | Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research? |
title_fullStr | Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research? |
title_full_unstemmed | Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research? |
title_short | Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research? |
title_sort | neglected infectious diseases: are push and pull incentive mechanisms suitable for promoting drug development research? |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592259/ https://www.ncbi.nlm.nih.gov/pubmed/23343639 http://dx.doi.org/10.1017/S1744133112000321 |
work_keys_str_mv | AT muellerlangerfrank neglectedinfectiousdiseasesarepushandpullincentivemechanismssuitableforpromotingdrugdevelopmentresearch |